Palvella Therapeutics (PVLA) EPS (Basic) Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.53% |
| Dec 31, 2025 | -32.95% |
| Sep 30, 2025 | -31.70% |
| Jun 30, 2025 | -57.05% |
| Mar 31, 2025 | -60.26% |
| Dec 31, 2024 | 31.95% |
| Sep 30, 2024 | -139.50% |
| Jun 30, 2024 | -59.40% |
| Mar 31, 2024 | -50.42% |
| Dec 31, 2023 | 151.04% |
| Sep 30, 2023 | -139.68% |
| Jun 30, 2023 | 295.47% |
| Mar 31, 2023 | -142.14% |
| Sep 30, 2022 | 4.07% |
| Jun 30, 2022 | 9.45% |
| Mar 31, 2022 | 18.10% |
| Dec 31, 2021 | 4.07% |
| Sep 30, 2021 | -11.38% |
| Jun 30, 2021 | -12.30% |
| Mar 31, 2021 | 6.89% |
| Dec 31, 2020 | -30.01% |
| Sep 30, 2020 | -21.06% |
| Jun 30, 2020 | 5.59% |
| Mar 31, 2020 | 11.65% |
| Sep 30, 2019 | 21.71% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | -23.36% |
| Dec 31, 2018 | -307.97% |
| Sep 30, 2018 | -158.96% |
| Jun 30, 2018 | -132.97% |